These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 17408810)

  • 41. Structural findings of 2-phenylindole-3-carbaldehyde derivatives for antimitotic activity by FA-sMLR QSAR analysis.
    Halder AK; Adhikari N; Jha T
    Chem Biol Drug Des; 2010 Feb; 75(2):204-13. PubMed ID: 20028392
    [TBL] [Abstract][Full Text] [Related]  

  • 42. 2D- and 3D-QSAR studies on 54 anti-tumor Rubiaceae-type cyclopeptides.
    Yan H; Pan X; Tan N; Fan J; Zeng G; Han H
    Eur J Med Chem; 2009 Sep; 44(9):3425-32. PubMed ID: 19303172
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacophore-based 3D-QSAR of HIF-1 inhibitors.
    Chung JY; Pasha FA; Cho SJ; Won M; Lee JJ; Lee K
    Arch Pharm Res; 2009 Mar; 32(3):317-23. PubMed ID: 19387572
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A three-dimensional quantitative structure-activity analysis of a new class of bisphenol topoisomerase IIalpha inhibitors.
    Liang H; Wu X; Yalowich JC; Hasinoff BB
    Mol Pharmacol; 2008 Mar; 73(3):686-96. PubMed ID: 18045852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Prado-Prado FJ; Martinez de la Vega O; Uriarte E; Ubeira FM; Chou KC; González-Díaz H
    Bioorg Med Chem; 2009 Jan; 17(2):569-75. PubMed ID: 19112024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Molecular modeling studies of phenoxypyrimidinyl imidazoles as p38 kinase inhibitors using QSAR and docking.
    Ravindra GK; Achaiah G; Sastry GN
    Eur J Med Chem; 2008 Apr; 43(4):830-8. PubMed ID: 17706839
    [TBL] [Abstract][Full Text] [Related]  

  • 47. QSAR analysis of antitumor active amides and quinolones from thiophene series.
    Bertosa B; Aleksić M; Karminiski-Zamola G; Tomić S
    Int J Pharm; 2010 Jul; 394(1-2):106-14. PubMed ID: 20472047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. QSAR studies of CYP2D6 inhibitor aryloxypropanolamines using 2D and 3D descriptors.
    Roy PP; Roy K
    Chem Biol Drug Des; 2009 Apr; 73(4):442-55. PubMed ID: 19291105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. QSAR analysis of 1,3-diaryl-4,5,6,7-tetrahydro-2H-isoindole derivatives as selective COX-2 inhibitors.
    Silakari P; Shrivastava SD; Silakari G; Kohli DV; Rambabu G; Srivastava S; Shrivastava SK; Silakari O
    Eur J Med Chem; 2008 Jul; 43(7):1559-69. PubMed ID: 18023931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel Biginelli dihydropyrimidines with potential anticancer activity: a parallel synthesis and CoMSIA study.
    Prashantha Kumar BR; Sankar G; Nasir Baig RB; Chandrashekaran S
    Eur J Med Chem; 2009 Oct; 44(10):4192-8. PubMed ID: 19525040
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Exploring molecular shape analysis of styrylquinoline derivatives as HIV-1 integrase inhibitors.
    Leonard JT; Roy K
    Eur J Med Chem; 2008 Jan; 43(1):81-92. PubMed ID: 17452064
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Molecular field analysis and 3D-quantitative structure-activity relationship study (MFA 3D-QSAR) unveil novel features of bile acid recognition at TGR5.
    Macchiarulo A; Gioiello A; Thomas C; Massarotti A; Nuti R; Rosatelli E; Sabbatini P; Schoonjans K; Auwerx J; Pellicciari R
    J Chem Inf Model; 2008 Sep; 48(9):1792-801. PubMed ID: 18698841
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Predicting anti-HIV activity of 1,3,4-thiazolidinone derivatives: 3D-QSAR approach.
    Ravichandran V; Prashantha Kumar BR; Sankar S; Agrawal RK
    Eur J Med Chem; 2009 Mar; 44(3):1180-7. PubMed ID: 18687505
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of CoMFA and CoMSIA models of cytotoxicity data of anti-HIV-1-phenylamino-1H-imidazole derivatives.
    Basu A; Jasu K; Jayaprakash V; Mishra N; Ojha P; Bhattacharya S
    Eur J Med Chem; 2009 Jun; 44(6):2400-7. PubMed ID: 19000644
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 3D QSAR CoMFA/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors.
    Durdagi S; Mavromoustakos T; Papadopoulos MG
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6283-9. PubMed ID: 18951793
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular modeling studies of N-substituted pyrrole derivatives--potential HIV-1 gp41 inhibitors.
    Teixeira C; Barbault F; Rebehmed J; Liu K; Xie L; Lu H; Jiang S; Fan B; Maurel F
    Bioorg Med Chem; 2008 Mar; 16(6):3039-48. PubMed ID: 18226912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Three-dimensional QSAR analyses of 1,3,4-trisubstituted pyrrolidine-based CCR5 receptor inhibitors.
    Zhuo Y; Kong R; Cong XJ; Chen WZ; Wang CX
    Eur J Med Chem; 2008 Dec; 43(12):2724-34. PubMed ID: 18538451
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular modeling of phenothiazines and related drugs as multidrug resistance modifiers: a comparative molecular field analysis study.
    Pajeva I; Wiese M
    J Med Chem; 1998 May; 41(11):1815-26. PubMed ID: 9599232
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CoMFA and HQSAR studies on 6,7-dimethoxy-4-pyrrolidylquinazoline derivatives as phosphodiesterase10A inhibitors.
    Kulkarni SS; Patel MR; Talele TT
    Bioorg Med Chem; 2008 Apr; 16(7):3675-86. PubMed ID: 18299198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. 20-(S)-camptothecin analogues as DNA topoisomerase I inhibitors: a QSAR study.
    Hansch C; Verma RP
    ChemMedChem; 2007 Dec; 2(12):1807-13. PubMed ID: 17886246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.